An immunotherapy drug that turns a patient’s own blood cells into cancer killers is on the fast track to FDA approval.
In an ongoing clinical trial, the treatment was administered to advanced lymphoma patients who had not responded to standard treatments or continued to relapse. At three months, 37 percent of patients showed no signs of cancer. As trials progress, scientists hope the therapy could be the next big step forward in cancer treatment. Make sure you always incorporate these cancer-fighting foods into your diet.